Women who have a cervix that is shorter than 25 mm, have a 70 percent greater risk of delivering their babies at less than 33 weeks of gestation. But research conducted in Detroit has uncovered a promising treatment for women with short cervixes -- vaginal progesterone.
David C. Warner is the Wilbur J. Cohen Fellow in Health and Social Policy at the Lyndon B. Johnson School of Public Affairs and a professor of public affairs at the University of Texas at Austin. He also is a visiting professor at the University of Texas School of Public Health in Houston. His major teaching and research interests are in economics, health policy and health finance. He formerly taught at Wayne State University and Yale University and was deputy director of the Office of Program Analysis of the New York City Health and Hospitals Corporation.
